Realm Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 370.69%
- Profit Growth 111.55%
- Ebitda 89.27%
- Net Worth 452.76%
- Total Assets 3.02%
About Realm Pharmaceuticals
Realm Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 September 2015 (Nine years and four months 19 days old ). Its registered office is in Yamuna Nagar, Haryana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sameer Sharma and Nitika Sharma serve as directors at the Company.
Company Details
-
Location
Yamuna Nagar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233HR2015PTC056663
-
Company No.
056663
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Realm Pharmaceuticals Private Limited offer?
Realm Pharmaceuticals Private Limited offers a wide range of products and services, including Arthritic Drugs, Aceclofenac Tablet, Anti Ulcer Drugs, Rabeprazole Sodium & Levosulpiride capsules.
Who are the key members and board of directors at Realm Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Sharma
|
Director | 15-Sep-2015 | Current |
|
Nitika Sharma
|
Director | 20-Aug-2022 | Current |
Financial Performance of Realm Pharmaceuticals.
Realm Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 370.69% increase. The company also saw a substantial improvement in profitability, with a 111.55% increase in profit. The company's net worth Soared by an impressive increase of 452.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Realm Pharmaceuticals?
In 2017, Realm Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Realm Pharmaceuticals?
Unlock and access historical data on people associated with Realm Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Realm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Realm Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
